TY  - JOUR
AU  - Pérez-García, Rafael
AU  - Varas, Javier
AU  - Cives, Alejandro
AU  - Martín-Malo, Alejandro
AU  - Aljama, Pedro
AU  - Ramos, Rosa
AU  - Pascual, Julio
AU  - Stuard, Stefano
AU  - Canaud, Bernard
AU  - Merello, José Ignacio
AU  - ORD group
PY  - 2018
DO  - 10.1093/ndt/gfx269
UR  - http://hdl.handle.net/10668/11688
T2  - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
AB  - Erythropoiesis-stimulating agents (ESAs) are widely used to treat anaemia in patients with chronic kidney disease. The issue of ESA safety has been raised in multiple studies, with correlates derived for elevated cancer incidence and mortality....
LA  - en
KW  - Aged
KW  - Female
KW  - Hematinics
KW  - Hospitalization
KW  - Humans
KW  - Male
KW  - Mortality
KW  - Prognosis
KW  - Propensity Score
KW  - Renal Dialysis
KW  - Renal Insufficiency, Chronic
KW  - Retrospective Studies
KW  - Survival Rate
TI  - Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.
TY  - research article
VL  - 33
ER  -